You are here

anti-clotting

With $25M-plus Aralez deal, Merck finds a buyer for abandoned clot-fighter Zontivity

Fierce Pharma

Sat, 09/10/16 - 09:48 am

Aralez Pharmaceuticals

Why the FDA Still Won’t Approve J&J’s Blood Clot Medicine

Wall St Cheat Sheet

Sat, 02/15/14 - 11:12 am

New clot preventer works as well as warfarin with less bleeding

Reuters

Sun, 06/30/13 - 10:49 am

Bristol-Myers Squibb

Eliqius A Huge Growth Catalyst For Bristol-Myers Squibb

Seeking Alpha

Sat, 12/15/12 - 12:51 pm

J&J again seeks more approvals for clot blocker

Yahoo/AP

Sat, 09/8/12 - 11:04 am

FDA Delays Eliquis Verdict

Yahoo/Zacks

Sat, 03/3/12 - 11:39 am

Bristol-Myers Squibb

Merck clot drug meets study goal but bleeding a risk

Reuters

Tue, 02/7/12 - 09:59 am

Bayer Seeks to Expand Xarelto's Label

Yahoo/Zacks.com

Tue, 01/3/12 - 10:45 am

Johnson & Johnson seeks FDA approval for third use for its new anticlotting drug, Xarelto

Yahoo/AP

Thu, 12/29/11 - 11:52 am

Pfizer, Bristol-Myers’ Eliquis Recommended by U.K. Cost Agency

Bloomberg

Sat, 11/26/11 - 10:33 am

Bristol-Myers Squibb

Boehringer says about 260 deaths related to Pradaxa

Reuters

Sat, 11/12/11 - 12:38 pm

Boehringer Ingelheim

oral anti-coagulant

Astellas halts development of anti-clotting drug

Reuters

Wed, 09/28/11 - 09:19 am

The Rivaroxaban (Xarelto) FDA Panel and Large Pragmatic Trials

Forbes

Sat, 09/10/11 - 10:25 am

atrial fibrillation

Merck returns $50M anti-clotting drug betrixaban to Portola

bizjournals.com

Thu, 03/24/11 - 03:14 pm

Portola Pharmaceuticals

ThromboGenics Seeks Cash Deal on Clot Drug to Fund Microplasmin

Bloomberg

Fri, 11/5/10 - 11:22 am

Medicines Co triumphs in decade-long patent fight

Yahoo/AP

Tue, 10/5/10 - 10:02 am

Medicines Company

Bayer Chief Envisions $15 Billion Market for Xarelto, New Blood Thinners

Bloomberg

Thu, 09/16/10 - 12:29 pm

Boehringer Ingelheim

Bristol-Myers Squibb

FDA extends time for AstraZeneca's ticagrelor NDA

Marketwatch

Wed, 09/15/10 - 08:04 am

Eisai's Anti-Clotting Drug May Cut Heart Risks Without Increased Bleeding

Bloomberg

Mon, 08/30/10 - 11:21 am

Momenta Gets FDA Green Light for Generic Anti-Clotting Drug

Motley Fool

Sat, 07/24/10 - 03:00 pm

Pages